11 May 2022 in Proceedings of the National Academy of Sciences
Significance: Neurons communicate by releasing neurotransmitters, many of which act at G protein–coupled receptors. Although it is well known that Gq/11accelerates action potential firing while Gi/oinhibits firing, how firing patterns change in response to simultaneous activation of Gq/11and Gi/oremains elusive, especially because the relative strength of Gq/11versus Gi/oactivation varies greatly from event to event. This study reveals that neurons encode distinct messages that reflect coincident Gq/11and Gi/ostimulation by activating two ion channels, TRPC4 and GIRK. The resulting firing patterns, composed of burst, pause, and firing recovery phases, reflect both the occurrence of coincident Gq/11and Gi/oactivation and their relative strengths. With these, we may begin to interpret the language of neurons.
4 October 2022 in bioRxiv
Nociceptive sensory neurons convey pain-related signals to the CNS using action potentials. Loss-of-function mutations in the voltage-gated sodium channel Na V 1.7 cause insensitivity to pain (presumably by reducing nociceptor excitability) but efforts to treat pain by inhibiting Na V 1.7 pharmacologically have largely failed. This may reflect the variable contribution of Na V 1.7 to nociceptor excitability. Contrary to claims that Na V 1.7 is necessary for nociceptors to initiate action potentials, we show that nociceptors can achieve equivalent excitability using different combinations of Na V 1.3, Na V 1.7, and Na V 1.8. Selectively blocking one of those Na V subtypes reduces nociceptor excitability only if the other two subtypes are weakly expressed. For example, excitability relies on Na V 1.8 in acutely dissociated nociceptors but responsibility shifts to Na V 1.7 and Na V 1.3 by the fourth day in culture. A similar shift in Na V dependence occurs in vivo after inflammation, impacting ability of the Na V 1.7-selective inhibitor PF-05089771 to reduce pain in behavioral tests. Flexible use of different Na V subtypes exemplifies degeneracy – equivalent function using different components – and compromises the reliable modulation of nociceptor excitability by subtype-selective inhibitors. Identifying the dominant Na V subtype to predict drug efficacy is not trivial. Degeneracy at the cellular level must be considered when choosing drug targets at the molecular level. SIGNIFICANCE STATEMENT: Nociceptors can achieve equivalent excitability using different sodium channel subtypes. The analgesic efficacy of subtype-selective drugs hinges on which subtype controls excitability. This contingency likely contributes to poor clinical outcomes.